- Home
- SUPN vs INSW Comparison
SUPN vs INSW Comparison
Compare SUPN & INSW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SUPN | INSW |
|---|---|---|
| Founded | 2005 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.6B |
| IPO Year | 2012 | N/A |
Fundamental Metrics
Financial Performance| Metric | SUPN | INSW |
|---|---|---|
| Price | $49.87 | $56.38 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | ★ $61.60 | $48.00 |
| AVG Volume (30 Days) | ★ 632.9K | 528.3K |
| Earning Date | 02-24-2026 | 02-26-2026 |
| Dividend Yield | N/A | ★ 5.20% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 4.39 |
| Revenue | $681,539,000.00 | ★ $770,036,000.00 |
| Revenue This Year | $8.32 | N/A |
| Revenue Next Year | $23.64 | $3.45 |
| P/E Ratio | ★ N/A | $12.84 |
| Revenue Growth | ★ 4.54 | N/A |
| 52 Week Low | $29.16 | $27.20 |
| 52 Week High | $57.65 | $57.36 |
Technical Indicators
Market Signals| Indicator | SUPN | INSW |
|---|---|---|
| Relative Strength Index (RSI) | 48.53 | 68.48 |
| Support Level | $49.41 | $54.27 |
| Resistance Level | $52.34 | $57.36 |
| Average True Range (ATR) | 1.62 | 1.83 |
| MACD | -0.21 | 0.74 |
| Stochastic Oscillator | 38.94 | 88.90 |
Price Performance
Historical ComparisonAbout SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.
About INSW International Seaways Inc.
International Seaways Inc owns and operates a fleet of oceangoing vessels engaged in the transportation of crude oil and petroleum products. The company's vessel operations are organized into two segments: Crude Tankers and Product Carriers. The fleet consists of ULCC, VLCC, Suezmax, Aframax, and Panamax crude tankers, as well as LR1, LR2, and MR product carriers.